Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

MedMira Inc

MIR.V ✓ COMPLIANTFree checks used up today ☆ Track — members

TSX · Healthcare · Advanced Medical Equipment & Technology ·

Canada Micro Cap Analyst: N/A

Last Close

$0.05

▲ +0.00%

Market Cap $35.24M · Vol 7.00K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$35.24M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

44.44

Momentum

Beta

0.82

vs Market

52W High

$0.08

37.96% below

52W Low

$0.04

29.49% above

Volume

7.00K

Avg 80.17K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

34.46%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, MedMira Inc (MIR.V) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MIR.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-7.14%

+8.33%

+0.00%

YTD

+0.00%

-18.75%

-30.18%

-56.67%

Financials & Valuation

TTM · Annual

Total Revenue	$173.63K
Net Income	$-3,266,250.00
Revenue Growth (YoY)	+307.99%
Gross Margin	71.87%
Operating Margin	-1,492.56%
Net Profit Margin	-1,881.18%
ROE	N/A
ROA · ROIC	-92.79% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	233.42
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	758.31M

Technical Indicators

50-Day SMA	$0.05
200-Day SMA	$0.05
RSI (14)	44.44
Beta	0.82
52-Week High	$0.08
52-Week Low	$0.04

Volume Today	7.00K
Avg Daily Volume (30D)	80.17K
Relative Volume	0.09x
Volatility (10D)	103.04
Volatility (30D)	95.94
Free Float	34.46%

Analyst Consensus

N/A

Current Price $0.05

Mean Target N/A

52W Low$0.04 52W High$0.08

Current

Target

$0.04 $0.08

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX

FIGIBBG001SDK915

ISINCA58501R1029

CountryCanada

Sub-IndustryMedical Diagnostic & Testing Equipment

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SRT.DE Sartorius AG +1.23% BIOT.ST Biotage AB +0.14% EUZ.DE Eckert & Ziegler SE +1.66% VREX Varex Imaging Corporation +0.38% CEVI.ST CellaVision AB +1.10%

Company Profile

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with an instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.